Trademark: 79299097
Word
DXCOVER
Status
Registered
Status Code
700
Status Date
Tuesday, September 14, 2021
Serial Number
79299097
Registration Number
6481155
Registration Date
Tuesday, September 14, 2021
Mark Type
4000
Filing Date
Friday, September 25, 2020
Published for Opposition
Tuesday, June 1, 2021

Trademark Owner History
DXCOVER LIMITED - Original Registrant
Clinspec Diagnostics Limited - Original Applicant

Classifications
9 Scientific apparatus and instruments for analysing biofluids and detecting diseases; laboratory apparatus and instruments for microscopy; scientific apparatus, namely, spectrometers and parts and fittings therefor; spectroscopes; scientific apparatus, namely, spectrophotometers for measuring the infrared spectrum of biofluids for the purpose of detecting diseases; spectrometry apparatus; spectrograph apparatus; data processing equipment, namely, couplers; downloadable computer software for use in medical and clinical analysis and disease diagnostics for analyzing medical data to assist in providing clinical interpretations; computer hardware; downloadable electronic publications in the nature of newsletters, reports and brochures in the field of science and medicine; data processing apparatus with artificial intelligence; downloadable artificial intelligence and machine learning software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids; parts and fittings for all the aforesaid goods; all of the aforesaid goods relating to spectroscopic analysis
44 Medical services; medical care services; health clinic services; healthcare services, namely, medical analysis services for diagnostic and treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing cancer screening services; preparation of medical reports relating to health care matters in the field of biofluid analysis and the detection of diseases for medical professionals and patients; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis of cancer; medical testing of blood; medical testing in the nature of liquid biopsy testing for medical purposes; advice, information and consultancy services for all of the aforesaid services; all of the aforesaid services relating to spectroscopic analysis
10 Medical apparatus and instruments for analysing biofluids and detecting diseases; diagnostic apparatus for medical purposes, namely, analysing biofluids and detecting diseases; medical apparatus for the treatment of cancer; blood testing apparatus; medical diagnostics instruments and apparatus for the analysis of bodily fluids; medical apparatus, instruments and devices for liquid biopsy analysis; parts and fittings for all the aforesaid goods; all of the aforesaid goods relating to spectroscopic analysis
42 Scientific and technological services, namely, research, design, analysis and testing in the field of medical and clinical analysis and disease diagnostics; industrial analysis and research services in the field of medical and clinical analysis and disease diagnostics; design and development of computer hardware and software; design and development of computer software for use with medical technology; engineering services and design services for scientific equipment and apparatus for microscopy, spectroscopy and scientific imaging; medical research services; clinical research in the field of biofluid analysis and disease detection; medical laboratory services; computer programming in the medical field; design and development of medical technology; design and development of medical diagnostic apparatus; blood analysis services; scientific research for medical purposes in the area of cancerous diseases; research in the field of artificial intelligence; providing on-line non-downloadable software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; analysis and evaluation of technical data, namely, scientific and medical data for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; technical support services, namely, computerised analysis of technical data; scientific and technological services, namely, overseeing, monitoring and managing scientific and medical experiments and tests in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, overseeing, monitoring and managing the analysis and evaluation of scientific and medical data in the field of medical and clinical analysis and disease diagnostics; design of scientific experiments; provision of scientific reports relating to scientific research in the field of medical and clinical analysis and disease diagnostics; advice, information and consultancy services for all of the aforesaid services; all of the aforesaid services relating to spectroscopic analysis
DX COVER

Trademark Events
Mar 21, 2022
Final Decision Transaction Processed By Ib
Mar 1, 2022
Final Disposition Notice Sent To Ib
Mar 1, 2022
Final Disposition Processed
Dec 14, 2021
Final Disposition Notice Created, To Be Sent To Ib
Sep 14, 2021
Registered-Principal Register
Aug 11, 2021
Extension Of Time To Oppose Process - Terminated
Jul 2, 2021
Change Of Name/Address Rec'd From Ib
Jul 1, 2021
Extension Of Time To Oppose Received
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 15, 2021
Change Of Name/Address Rec'd From Ib
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 26, 2021
Approved For Pub - Principal Register
Apr 26, 2021
Examiner's Amendment Entered
Apr 26, 2021
Notification Of Examiners Amendment E-Mailed
Apr 26, 2021
Examiners Amendment E-Mailed
Apr 26, 2021
Examiners Amendment -Written
Apr 24, 2021
Teas/Email Correspondence Entered
Apr 23, 2021
Correspondence Received In Law Office
Apr 23, 2021
Teas Response To Office Action Received
Mar 22, 2021
Refusal Processed By Ib
Mar 4, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Mar 4, 2021
Refusal Processed By Mpu
Feb 22, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Feb 21, 2021
Non-Final Action Written
Feb 17, 2021
Assigned To Examiner
Dec 8, 2020
Application Filing Receipt Mailed
Dec 4, 2020
New Application Office Supplied Data Entered In Tram
Dec 3, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24